NCL-CB11, a new monoclonal antibody recognizing the internal domain of the c-erbB-2 oncogene protein effective for use on formalin-fixed, paraffin-embedded tissue-Reference-Cited by-同舟云学术

NCL-CB11, a new monoclonal antibody recognizing the internal domain of the c-erbB-2 oncogene protein effective for use on formalin-fixed, paraffin-embedded tissue

Published:1990-05 Issue:1 Volume:161 Page:15-25
ISSN:0022-3417
Container-title:The Journal of Pathology
language:en
Short-container-title:J. Pathol.

Author:

Corbett Ian P.,Henry James A.,Angus Brian,Watchorn Caroline J.,Wilkinson Linda,Hennessy Colm,Gullick William J.,Tuzi Nadia L.,May Felicity E. B.,Westley Bruce R.,Horne Charles H. W.

Publisher

Wiley

Subject

Pathology and Forensic Medicine

Reference36 articles.

1. Localization of a novel v-erbB-related gene, c-erbB-2, on human chromosome 17 and its amplification in a gastric cancer cell line.

2. The neu oncogene: an erb-B-related gene encoding a 185,000-Mr tumour antigen

3. The neu Gene: an erb B-Homologous Gene Distinct from and Unlinked to the Gene Encoding the EGF Receptor

4. Single-step induction of mammary adenocarcinoma in transgenic mice bearing the activated c-neu oncogene

5. Stochastic appearance of mammary tumors in transgenic mice carrying the MMTV/c-neu oncogene

Cited by 111 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Molecular and clinicopathological characteristics of ERBB2 gene fusions in 32,131 Chinese patients with solid tumors;Frontiers in Oncology;2022-10-06

2. The VEGF and HER2 Expressions as Prognostic Factors in Osteosarcoma Patients;SSRN Electronic Journal;2022

3. Human epidermal growth factor receptor 2 expression in head and neck squamous cell carcinoma: Variation within and across primary tumor sites, and implications for antigen‐specific immunotherapy;Head & Neck;2021-03-04

4. Cross-reactivity of EGFR Mutation-specific Immunohistochemistry Assay in HER2-positive Tumors;Applied Immunohistochemistry & Molecular Morphology;2015-09

5. Human epidermal growth factor receptor 2 (HER2) immunoreactivity: specificity of three pharmacodiagnostic antibodies;Histopathology;2011-11